MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discovery, development, and ...

A preview of the teams and swimmers to watch at the weather-delayed 6A and 5A swimming meets that will be held Monday and ...

MiNK Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of allogeneic invariant natural killer T (iNKT) cell therapies for cancer and immune-mediated ...

Mink Ventures Corporation (TSXV:MINK) (“Mink” or the "Company") today announced that it has completed all share issuances and incurred all expenditures required to earn a 100% interest in the Warren ...

纽约 - 专注于开发iNKT细胞疗法用于治疗癌症和其他疾病的生物制药公司MiNK Therapeutics, Inc. (NASDAQ: INKT)宣布已重新符合纳斯达克的上市要求。该公司目前股价为$9.49，年初至今回报率达36%，尽管市值相对较小，为$37.64million，但展现出强劲的韧性。根据 InvestingPro ...

TORONTO, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Mink Ventures Corporation (TSXV:MINK) (“Mink” or the "Company") today announced that it has completed all share issuances and incurred all ...

A couple loved that their apartment was used as a location for the movie ‘Philadelphia.’ But a decade after moving in, they ...

Mink Ventures Corporation (TSXV:MINK) ("Mink" or the "Company") today announced that it has completed all share issuances and incurred all expenditures required ...

NEW YORK - MiNK Therapeutics, Inc. (NASDAQ: INKT), a biopharmaceutical company focused on developing iNKT cell therapies for cancer and other diseases, has announced that it has regained ...

The Mellon Foundation sees equity as central to the depiction of America. In 2020, the Foundation decided to center its grantmaking initiatives on social justice, with the goal of influencing cultural ...